Medsir
Clinical trials sponsored by Medsir, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for breast cancer patients with brain tumors: targeted drug shows promise Results expected Nov 2026 (estimated)
- New radioactive 'Theranostic' drugs aim to find and treat brain tumors Results expected Nov 2026 (estimated)
- New drug shows promise for Hard-to-Treat breast cancer subtype Results expected Jan 2027 (estimated)
- New combo therapy shows promise for Hard-to-Treat breast cancer Results expected Feb 2027 (estimated)
- Could a Chemo-Free cocktail beat early breast cancer? Results expected Mar 2027 (estimated)
-
New hope for hard-to-treat breast cancer: drug duo targets hidden mutations
Disease control Not yet recruitingThis study tests a combination of two drugs, zongertinib and fulvestrant, in people with advanced breast cancer that is hormone receptor-positive and HER2-negative but has a specific HER2 gene mutation. The goal is to see if the combination shrinks tumors. About 25 adults will ta…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail aims to tame advanced breast cancer
Disease control Not yet recruitingThis study tests a new combination of drugs (zanidatamab, tucatinib, and chemotherapy) in people with advanced HER2-positive breast cancer that cannot be removed by surgery or has spread. The goal is to find the safest dose and see if the treatment shrinks tumors. About 24 adults…
Phase 1/2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New radioactive 'Theranostic' drugs aim to find and treat brain tumors
Disease control Not yet recruitingThis study tests special radioactive drugs that can both find and treat solid tumors that have spread to the brain. Ten adults with advanced breast cancer and active brain metastases will receive a single dose of a diagnostic agent to see if it lights up the brain tumors on a sca…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New study aims to stop Chemo-Induced diarrhea in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether giving atropine before treatment can prevent diarrhea in people with advanced breast cancer receiving the drug sacituzumab govitecan. About 30 participants will receive atropine alongside their cancer therapy. The goal is to improve treatment tolerance an…
Phase 2 • Sponsor: MedSIR • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Old tumor samples may hold key to future biliary cancer treatments
Knowledge-focused Not yet recruitingThis study will examine stored tumor samples from 244 people diagnosed with biliary tract cancer in the last 15 years. Researchers will measure five specific markers (CLDN18.2, HER2, TROP2, PD-L1, and B7-H4) to see how common they are and how they relate to patient outcomes. The …
Sponsor: MedSIR • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC